121 related articles for article (PubMed ID: 2204325)
21. The role of infections with Yersinia pseudotuberculosis and Yersinia enterocolitica in the pathogenesis of chronic inflammatory, rheumatic and collagen diseases.
Georgescu C; Dan E; Cojocaru M; Plosceanu L
Med Interne; 1986; 24(3):217-20. PubMed ID: 3534995
[TBL] [Abstract][Full Text] [Related]
22. [Role of biologically active substances in the pathogenesis of the allergic component of pseudotuberculosis in children].
Protasenia II
Pediatriia; 1985 Jul; (7):51-2. PubMed ID: 3900918
[No Abstract] [Full Text] [Related]
23. [Pseudotuberculosis from the clinical point of view (synonyms: Yersinia pseudotuberculosis infection, Pasteurella pseudotuberculosis infection, lymphadenitis mesenterialis Masshoff)].
Bretschneider R; Kirmse H
Z Arztl Fortbild (Jena); 1974 Jun; 68(12):592-8. PubMed ID: 4611060
[No Abstract] [Full Text] [Related]
24. [Components of the outer membrane of Yersinia pseudotuberculosis and their role in the pathogenesis of pseudotuberculosis].
Timchenko NF; Novikova OD; Ermak IP; Solov'eva TF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):38-41. PubMed ID: 3019047
[TBL] [Abstract][Full Text] [Related]
25. Haemophilia-associated Yersinia pseudotuberculosis serotype O:1 septicaemia: the role of iron.
Mischnik A; Dahme T; Bekeredjian R; Zimmermann S
J Med Microbiol; 2012 Jan; 61(Pt 1):157-159. PubMed ID: 22184209
[TBL] [Abstract][Full Text] [Related]
26. [Staged treatment and follow-up of patients with yersinia infections].
Gordeets AV; Beniova SN; Shumatova TA
Klin Med (Mosk); 1994; 72(2):42-5. PubMed ID: 8015242
[TBL] [Abstract][Full Text] [Related]
27. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
[No Abstract] [Full Text] [Related]
28. Unilateral inguinal lymphadenitis caused by Yersinia pseudotuberculosis. A case report.
Iwata K; Morishita N; Masuda Y; Kodama M; Otani S; Naito A
J Infect Chemother; 2020 Jul; 26(7):762-764. PubMed ID: 32386928
[TBL] [Abstract][Full Text] [Related]
29. [Recurrences of pseudotuberculous infection and the status of cellular immunity].
Malyĭ VP; Timchenko NF; Dzadzieva MF
Ter Arkh; 1983; 55(10):58-9. PubMed ID: 6359542
[No Abstract] [Full Text] [Related]
30. [Analysis of the plasmid composition of Yersinia pseudotuberculosis strains and its use for typing pseudotuberculosis pathogens].
Shubin FN; Gintsburg AL; Kitaev VM; Ianishevskiĭ NV; Zenkova ZG
Mol Gen Mikrobiol Virusol; 1989 Jun; (6):20-5. PubMed ID: 2682219
[TBL] [Abstract][Full Text] [Related]
31. [Clinical aspects, pathogenesis and treatment of Yersinia infections].
Iushchuk ND; Karetkina GN; Proskurina LN; Malov IV; Via'lba EV
Klin Med (Mosk); 1989 May; 67(5):91-7. PubMed ID: 2671487
[No Abstract] [Full Text] [Related]
32. Yersinia pseudotuberculosis infection in children. Clinical manifestations and epidemiology.
Sato K
Contrib Microbiol Immunol; 1987; 9():111-6. PubMed ID: 3311631
[No Abstract] [Full Text] [Related]
33. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
34. [An analysis of the antibodies to the outer cell membrane proteins in Yersinia in the varying course of human pseudotuberculosis].
Malov IV; Shurygina IA; Volchenko IuE
Ter Arkh; 1994; 66(4):62-4. PubMed ID: 8016734
[TBL] [Abstract][Full Text] [Related]
35. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
36. [Morphologic findings and immunopathogenetic correlations in a case of Yersinia pseudotuberculosis type 1 mesenteric lymphadenitis].
Caruso R; Barresi G; Chimicata S; De Leo F
Pathologica; 1982; 74(1032):533-43. PubMed ID: 6761636
[No Abstract] [Full Text] [Related]
37. [Pathogenesis and pathologic anatomy of human Yersinia infections].
Kühn H; Freissler G
Leber Magen Darm; 1983 Nov; 13(6):270-7. PubMed ID: 6392801
[TBL] [Abstract][Full Text] [Related]
38. In vivo immunosuppression induced by a virulent strain of Yersinia pseudotuberculosis.
Simonet M; Berche P
Ann Inst Pasteur Microbiol; 1986; 137B(2):207-10. PubMed ID: 3318867
[No Abstract] [Full Text] [Related]
39. [The first case of pseudotuberculosis found in China].
Li GH
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Jun; 10(3):146-8. PubMed ID: 2673528
[TBL] [Abstract][Full Text] [Related]
40. Some aspects of the immunology of pseudotuberculosis.
Besednova NN; Somov GP
J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):235-41. PubMed ID: 6754810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
